baber/WOPTO huggingface dataset:
Patent EP-2362832-A2 (EP)
Inventor: SCHNEIDER THOMAS W
IPC: B41F13/14
Filed: 2009-11-18
Abstract: L'invention divulgue un dispositif et un procédé d'impression flexographique qui utilisent une plate-forme de support attachée à un cadre d'imprimante et quatre chariots de support de palier attachés à la plate-forme de support afin de supporter de façon opérationnelle des extrémités opposées d'un cylindre toucheur et un cylindre anilox. Un chariot de cylindre toucheur et un chariot de cylindre anilox sont attachés de façon opérationnelle à la plate-forme de support le long de chaque côté opposé de la plate-forme de support par un arrangement de guidage linéaire commun. Les chariots de cylindre toucheur sont positionnés le long des arrangements de guidage linéaires par deux positionneurs linéaires de cylindre toucheur attachés de façon opérationnelle entre la plaque de support. Les chariots anilox sont positionnés le long des arrangements de guidage linéaires par rapport aux chariots de cylindre toucheur par une paire de positionneurs linéaires de cylindre anilox qui sont attachés de façon opérationnelle entre les chariots de cylindre toucheur et de cylindre anilox. La plate-forme de support peut en outre se déplacer transversalement par rapport au cadre d'imprimante en vue d'un repérage latéral.
Patent EP-2189934-A2 (EP)
Inventor: DAVIS WALTER LEE
IPC: G06Q40/00
Filed: 1998-12-04
Abstract: A secure messaging system (900) includes a secure messaging system controller (1702) and optionally one or more financial messaging units (106, 906, 1704, 1706). The secure messaging system controller includes a financial account event monitor (1760) and a schedule controller (1750). The financial account event monitor stores and monitors financial account event triggers associated with a plurality of financial accounts. The schedule controller schedules transmission of at least one financial transaction message to effect a financial transaction responsive to a determination of an occurrence of at least one financial account event trigger by the financial account event monitor in connection with a financial account of the plurality of financial accounts. The financial transaction is associated with the at least one financial account event trigger, and each financial transaction message includes a transaction identifier that identifies a corresponding portion of the financial transaction and further includes a value associated with the corresponding portion of the financial transaction.
Patent EP-2246240-A2 (EP)
Inventor: HORNSMANN MARTIN
IPC: B62D21/12
Filed: 2010-02-25
Abstract: Cross-member link-up areas (10,11) and with them allocated mounting-bracket link-up areas (7,8) are inclined/tilted towards the longitudinal direction of cross-members at a preset angle in such a way that opposing cross-member link-up areas and with them allocated mounting-bracket link-up areas are set up like a V or like an arrow.
Patent EP-2278123-A2 (EP)
Inventor: POP JULIAN J
IPC: E21B33/124
Filed: 2010-06-09
Abstract: An apparatus for obtaining a fluid at a position within a wellbore that penetrates a subterranean formation includes a body adapted to be disposed in the wellbore on a conveyance equipped with one or more expandable packers providing a sample region disposed between an upper cleanup zone and a lower cleanup zone when expanded into abutting contact with the wellbore wall; an upper cleanup port provided at the upper cleanup zone; a lower cleanup port provided at the lower cleanup zone; at least one fluid cleanup flowline in fluid connection with the upper and lower cleanup ports; a sampling inlet provided at the sampling region; and a sampling flowline in fluid connection with the sampling inlet for drawing fluid from the sampling region.
Patent EP-2233156-A2 (EP)
Inventor: BELIVEAU RICHARD
IPC: A61K47/42
Filed: 2006-07-14
Abstract: Conjugates comprising carriers selected from the group consisting of aprotinin, a biologically active aprotinin fragment, Angiopep-1, Angiopep-2 and biologically active analogs, derivatives or fragments thereof and a label or drug are disclosed. Said conjugates increase the potency of the drug and modify the pharmacokinetics of the drug or label. The use of these conjugates in the treatment and diagnosis of cancer is described
Patent EP-2284860-A2 (EP)
Inventor: PUMP WOLFGANG
IPC: H01C3/06
Filed: 2010-08-04
Abstract: The electrical resistance (1) has a resistance element (2) and two connecting pieces (3,4) assigned to the resistance element. The resistance element is formed from a stack of partial-metal sheet pieces (5,6,7,8,9,10, 11). The partial-sheet metal pieces are arranged with their broad sides parallel to each other and in a stacking direction behind one another and spaced from each other. Independent claims are also included for the following: (1) a method for manufacturing an electrical resistance; and (2) an electric installation switching device with a contact point.
Patent EP-2270783-A2 (EP)
Inventor: KIM JIN YONG
IPC: G11B7/24067
Filed: 2003-07-01
Abstract: An apparatus for reproducing data from a recording medium, is disclosed, wherein the recording medium includes an information area including a lead-in area, a data area and a lead-out area. The apparatus comprises a pickup configured to read disc identification information identifying a type of the recording medium recorded in an area preceding the lead-in area and a controller configured to control the pickup to read disc control information data used to control data recording or reproduction to or from the data area. Data is recorded in the data area in a format unique to the type of the computer readable medium, and the type of recording medium is one of Read-Only, Recordable, and Rewritable types. 
     Furthermore, a method of reproducing data from a recording medium and a recording medium are disclosed.
Patent EP-2292255-A2 (EP)
Inventor: EIBL JOHANN
IPC: A61K38/37
Filed: 2003-12-18
Abstract: Storable pharmaceutical composition (A), made from virus-free active ingredient compositions (B) that contain at least one intact therapeutic protein (I), obtained from plasma or by genetic engineering methods, as active component. (B) do not contain enzymes (II), particularly proteases, either in free form or bound to their substrates, that are directed against (I). Independent claims are also included for the following: (1) (I), for preparation of (A) containing one or more atoxic, virus-free, high molecular weight enzyme inhibitors (III) at a final concentration that does not affect activity of (I); (2) purification process for recovering (I) from blood or biomass, designed to remove (II); (3) viral inactivation of (I), free of (II), by adding a virucidal chemical (IV) at room or elevated temperature, then removing (IV); (4) plasma (P) for recovery of crude fractions, intended for preparation of (I), that, immediately after separation from blood, is treated with atoxic complexing agents or sodium citrate until the calcium ion activity is below that of a 10 MicroM calcium chloride solution, and the treated plasma is processed or stored at -20 [deg]C; (5) cryoprecipitate or supernatant prepared by the method of (4); (6) virus-free fibrinogen (Fng) containing less than 4% Fng monomer complex, based on coagulatable protein, and less than 1 Microunit (MicroU) thrombin per mg Fng; (7) Fng-containing pharmaceutical (A') that can be stored as liquid, with thrombin activity below 1 MicroU/mg Fng and, by addition of an atoxic, chaotropic agent, can be stored at 2-8 [deg]C without formation of a gel; (8) purified thrombin, free of plasmin or other fibrinolytic proteases, that forms, at mixing ratio 500 U thrombin with 3 mg Fng, fibrin that does not undergo lysis after 10 hours at room temperature; (9) solution of immunoglobulin G (IgG) that contains less than 100 MicroU plasmin per mg IgG and no detectable kallikrein, or factors (F) IXa or XIIa, in a 10% Ig solution; (10) virus-free FVIII composition with no detectable thrombin activity and antithrombin activity less than 10 arbitrary units per unit FVIII, with up to 20% of FVIII in active form; (11) composition containing coagulations factors II, VII, IX and X, but less than 100 MicroU thrombin per 100 units FII, less than 1 MicroU FVIIa per 100 U FVII, less than 1 mU FIXa per 100 U FIX and less than 100 MicroU FXa per 100 units FX; (12) method and (composite) reagents able to detect or determine enzymes, even in presence of their natural substrates, after incubation for 10-1000, preferably 30-100, hours, in the pico- or femto-molar range at 0-45[deg]C; and (13) detecting and determining micro- or femto-molar concentrations of enzymes present in (I) prepared by the new method, by mass spectrometry, HPLC, gel filtration, or chromatographic, electrophoretic or immunological methods. ACTIVITY : Vasotropic. MECHANISM OF ACTION : None given.
Patent EP-2236325-A2 (EP)
Inventor: VANRAAPHORST DAVID
IPC: B60G17/048
Filed: 2010-03-26
Abstract: An active air suspension system includes an air spring assembly that has a piston airbag and a primary airbag mounted around the piston airbag to provide a variable force and rate dual air spring configuration. The air suspension system is configured to accurately control pressure within the piston airbags in a closed-loop manner. Continuous control of the piston pressure provides an accurate increase or decrease of spring rate or force depending on the controller inputs.
Patent EP-2196154-A2 (EP)
Inventor: THOMPSON STANLEY O
IPC: A61B19/00
Filed: 2006-08-10
Abstract: The present invention provides for exemplary embodiments of a single-insertion, multiple sampling biopsy device. Exemplary embodiments of a single-insertion, multiple sampling device with integrated marker release.
Patent EP-2236219-A2 (EP)
Inventor: UEBAYASHI SHIGEKI
IPC: B07B1/42
Filed: 2010-03-31
Abstract: A purifier (1) is provided that is capable of uniformly sucking powder in a width direction of the sieve layers (4) even when the purifier is configured to be provided with an air distribution chamber formed as being tapered upward and to have a horizontal cyclone provided above the air distribution chamber. 
     The air distribution chamber (18) is configured of paired inclined surfaces (18a,18b) formed as being tapered upward, has a suction passage formed as a horizontal cyclone (21) placed above the air distribution chamber. Also, a plurality of barrier walls (53) are provided in the air distribution chamber in a direction perpendicular to a longitudinal direction of sieve layers (4), the air distribution chamber (18) is sectioned by the barrier walls (53) into a plurality of chambers, and rectifying plates (20) are further provided to the air distribution chamber (18) at a narrow position between the paired inclined surfaces (18a,18b) to prevent non-uniformity of suction of powder on the sieve layers (4).
Patent EP-2287423-A2 (EP)
Inventor: PAPAGELIDIS MARIO
IPC: E05B9/10
Filed: 2010-08-02
Abstract: The element (3) has a knob (2) including hand contact surfaces (4-6) and connected with the element by a drive shaft (7). A rotatable sleeve (31) is rotatably-mounted on a section (7') of the drive shaft between the knob and a locking cylinder housing (1). The hand contact surfaces include cylindrical-shaped surface sections released by another section with large outer diameter in a direction at an axis of the drive shaft. The knob includes an apex region rounded in an axial cross section.
Patent EP-2292825-A2 (EP)
Inventor: TOKURA MASASHI
IPC: D05B19/12
Filed: 2010-08-06
Abstract: An image is captured of at least one marker (180, 281, 282) that is positioned on at least one of an embroidery frame (84, 384) that is r attached to a carriage (22) and a work cloth (39) that is held by the embroidery frame (one of Step S60 and Step S100). First marker data are computed based on generated image data (one of Step S65 and Step S110). The computed first marker data are transmitted to a sewing machine that will be used afterward (Step S70). The first marker data that are transmitted from another sewing machine are acquired as second marker data (Step S80). A sewing condition is acquired (Step S80). Pattern data are acquired in accordance with a pattern condition (Step S85). A correction condition is computed (Step S115). A partial pattern is sewn in accordance with the corrected pattern data (Step S130).
Patent EP-2296056-A2 (EP)
Inventor: YAMASHINA RYOTA
IPC: G03G15/20
Filed: 2010-09-03
Abstract: A fixing device (20) for fixing an image on a recording medium includes an endless flexible fixing member (21) formed into a loop, a heat conductive member (22) disposed within the loop formed by the fixing member (21), a heater (25, 45) disposed near the heat conductive member (22) to heat the heat conductive member (22), a pressing member (31) pressing the fixing member (21) against the heat conductive member (22) to form a fixing nip, a temperature sensor (28) detecting a temperature of the fixing member (21), and a lubricant (40) disposed between the fixing member (21) and the heat conductive member (22). The heater (25, 45) heats the heat conductive member (22) to heat the lubricant (40) with the fixing member (21) stopped. The fixing member (21) rotates after heating of the heat conductive member (22) by the heater (25, 45).
Patent EP-2343042-A2 (EP)
Inventor: VIRAVAU VALERIE
IPC: A61K8/81
Filed: 2010-12-17
Abstract: Cosmetic composition, comprises: (i) one or more organosilicon compounds comprising silanes containing a silicon atom and siloxane comprising two or three silicon atoms, where the organosilicon compounds further comprises one or more basic chemical functions and one or more hydroxyl groups or hydrolyzable groups by molecule; (ii) one or more anionic surfactants, and (iii) one or more cationic polymers in a medium. An independent claim is included for method for the treatment of keratin fibers, preferably human keratin fibers such as hair comprising applying the cosmetic composition on the fibers, and rinsing after a possible exposure time.
Patent EP-2311998-A2 (EP)
Inventor: PANDEY AWADH B
IPC: C22C1/04
Filed: 2010-08-19
Abstract: A method for producing a high strength aluminum alloy tubing containing L1 2  dispersoids from an aluminum alloy powder containing the L1 2  dispersoids. The powder is consolidated into a billet having a density of about 100 percent. The tube is formed by at least one of direct extrusion, Mannesmann process, pilgering, and rolling.
Patent EP-2387833-A2 (EP)
Title: Procédé et appareil de transmission d'indicateur de surcharge par liaison radio
Inventor: PALANKI RAVI
IPC: H04L5/00
Filed: 2010-01-15
Abstract: La présente invention concerne des techniques de transmission d'indicateurs de surcharge par liaison radio à des UE dans des cellules voisines. Dans un mode de réalisation, un indicateur de surcharge peut être transmis en tant que différence de phase entre au moins un signal de synchronisation et un signal de référence pour une cellule. Dans un autre mode de réalisation, un indicateur de surcharge peut être transmis en tant que différence de phase entre des transmissions consécutives d'au moins un signal de synchronisation pour une cellule. Dans un autre mode de réalisation, un indicateur de surcharge peut être transmis par une cellule sur des ressources réservées à la transmission de l'indicateur de surcharge. Dans un autre mode de réalisation, un indicateur de surcharge peut être transmis par une cellule sur un canal à faible réutilisation ou un canal de diffusion. Dans tous les modes de réalisation, un UE peut recevoir des indicateurs de surcharge provenant de cellules voisines, déterminer la charge de chaque cellule voisine sur la base de l'indicateur de surcharge pour la cellule concernée, et commander son actionnement sur la base de la charge des cellules voisines.
Patent EP-2380126-A2 (EP)
Title: Présentation, suivi et remboursement d'incitation conditionnelle
Inventor: PARETTI CHRISTOPHER T
IPC: G06Q30/00
Filed: 2010-01-14
Abstract: Selon l'invention, une offre est présentée à un utilisateur via un dispositif utilisateur. Les termes de l'offre contiennent une activité à exécuter ou un comportement à respecter, ainsi qu'une incitation destinée à récompenser l'exécution de l'activité ou le respect du comportement. On détermine si l'utilisateur a exécuté l'activité ou a respecté le comportement sur la base d'au moins des données spatiales, temporelles, sociales et/ou spécifiques obtenues via un moteur de suivi basé sur le réseau. S'il est déterminé que l'utilisateur a exécuté l'activité ou a respecté le comportement, il reçoit l'incitation.
Patent EP-2392016-A2 (EP)
Title: Système de solénoïde doté d'un organe d'induit segmenté permettant de réduire la force radiale
Inventor: DELAND DANIEL L
IPC: H01F7/08
Filed: 2010-01-20
Abstract: L'invention concerne un système de solénoïde comportant un organe d'induit qui est segmenté afin de minimiser la force radiale due à l'excentricité de l'organe d'induit. Le système de solénoïde comporte une bobine magnétique qui, une fois alimentée en énergie, créera un flux magnétique dans le chemin de flux. Une pièce polaire est en partie circonscrite par l'organe d'induit. Des entrefers interne et externe sont situés autour de l'organe d'induit. L'excentricité de l'organe d'induit conduit à une diminution dans l'un des entrefers et à une augmentation correspondante dans l'autre. Des espacements radiaux segmentent l'organe d'induit pour interrompre le chemin de flux circonférentiel autour de l'organe d'induit pour inhiber le tourbillonnement du flux magnétique vers le côté le plus proche de la pièce polaire et pour distribuer le flux magnétique de manière sensiblement uniforme. La force radiale agissant sur l'organe d'induit est réduite, ce qui entraîne une réduction du frottement entre les composants du solénoïde tout en préservant sensiblement le niveau souhaitable de force axiale.
Patent EP-2409268-A2 (EP)
Inventor: KIM YE-JEONG
IPC: G06Q30/02
Filed: 2010-03-15
Abstract: Systems and methods for editing online advertising campaigns from a summary interface. A summary interface can be provided. The summary interfaces shows filed fields associated with one or more advertising campaigns in a view mode. Upon receipt of a request to edit one or more of the fields, the summary interface transitions to an edit mode for editing of the selected fields and editing of hidden fields that are associated with the selected fields and that are not displayed in the view mode.
Patent EP-2416784-A2 (EP)
Inventor: TURKSON JAMES
IPC: A61K31/025
Filed: 2010-04-05
Abstract: The present invention provides compounds S3I-201.1066 (Formula 1) and S3I-201.2096 (Formula 2) as selective Stat3 binding agents that block Stat3 association with cognate receptor pTyr motifs, Stat3 phosphorylation and nuclear translocation, Stat3 transcriptional function, and consequently induced Stat3-specific antitumor cell effects  in vitr o and antitumor response  in vivo .
Patent EP-2504902-A2 (EP)
Title: Diagnose von relais in einer batterie
Inventor: STECK ARMIN
IPC: H02J7/00
Filed: 2010-09-27
Abstract: Ein Batteriesystem mit einer Mehrzahl von Batteriezellen (10), welche in Reihe zwischen einen ersten Batteriepol und einen zweiten Batteriepol geschaltet sind, einem zwischen den ersten Batteriepol und einen ersten Ausgang des Batterie- Systems geschalteten ersten Relais (11), einem zwischen den zweiten Batteriepol und einen zweiten Ausgang des Batteriesystems geschalteten zweiten Relais (12) und einem Controller. Das Batteriesystem weist ein drittes Relais (13) auf, welches in Serie zu einem ersten Widerstand (14) vorbestimmter Größe zwischen den ersten Batteriepol und den ersten Ausgang des Batteriesystems und parallel zum ersten Relais (11) geschaltet ist. Der Controller ist mit den Relais (11, 12, 13) verbunden und ausgebildet ist, die Relais (11, 12, 13) durch Ausgeben eines jeweiligen Steuersignals zu öffnen oder zu schließen.
Patent EP-2449091-A2 (EP)
Title: Procédés biologiques pour préparer de l'acide adipique
Inventor: PICATAGGIO STEPHEN
IPC: C12N1/21
Filed: 2010-07-01
Abstract: Cette invention concerne, en partie, des procédés biologiques pour produire de l'acide adipique et des micro-organismes génétiquement modifiés capables de le produire.
Patent EP-2449368-A2 (EP)
Title: Appareil de surveillance de fluide
Inventor: BAUM THOMAS H
IPC: G01D13/00
Filed: 2010-06-23
Abstract: L'invention porte sur un appareil de surveillance de fluide, comprenant un boîtier de circuit contenant un circuit destiné à traiter des signaux de détection de fluide et à transmettre une sortie en réponse, avec un ensemble capteur conçu pour être couplé mécaniquement et électriquement au boîtier de circuit. L'ensemble capteur comprend au moins un élément sensible conçu pour répondre à une espèce fluide d'intérêt dans le fluide surveillé par génération d'une sortie. L'appareil comprend au moins un élément parmi (A) une carte de circuit imprimé conçue pour entrer en prise avec le boîtier de circuit et pour être couplée mécaniquement à l'ensemble capteur, (B) l'ensemble capteur comprenant une base et un élément sensible relié de façon amovible à la base par des éléments de couplage à ajustement forcé, et (C) l'ensemble capteur comprenant une base et un filament sensible connecté à celle-ci, et un élément de protection de filament pour entourer le filament sensible de façon protectrice.
Patent EP-2512414-A2 (EP)
Inventor: MATHONNEAU ESTELLE
IPC: A61K8/86
Filed: 2010-12-14
Abstract: The invention relates to a composition for washing and conditioning keratin material, comprising the following constituents in a cosmetically acceptable medium, namely: one or more anionic surfactants; one or more liquid fatty alcohols; and one or more ethers of fatty alcohol and oxyethylenated polyol, having formula (I). The invention also relates to the use of the aforementioned composition for washing and conditioning keratin material and to a method for washing and conditioning keratin material using said composition.
Patent EP-2515934-A2 (EP)
Title: Compositions vaccinales
Inventor: AHMED SYED SALEEM
IPC: C07K14/705
Filed: 2010-12-08
Abstract: La présente invention porte sur des compositions de vaccin, en particulier des conjugués KLH-peptide, et sur des procédés de fabrication de telles compositions. La présente invention porte en outre sur des procédés de réduction d'une croissance anormale de cellules à l'aide des compositions de la présente invention.
Patent EP-2490719-A2 (EP)
Title: Méthodes d'utilisation d'anticorps anti-cd3 pour éviter le gain de poids
Inventor: BRENNAN AOIFE
IPC: A61K39/395
Filed: 2010-10-20
Abstract: Cette invention concerne des méthodes d'administration d'anticorps anti-CD3 ou de fragments de liaison antigénique chez l'homme pour réduire le gain de poids ou pour augmenter la perte de poids. Dans certains modes de réalisation, l'homme présente un indice de masse corporelle (IMC) supérieur ou égal à 27. Dans certains modes de réalisation, l'anticorps anti-CD3 ou le fragment de liaison antigénique ne se fixe pas ou se fixe difficilement à une classe au moins de récepteurs Fc (gamma).